• Small and medium-sized enterprises (SMEs) and mid-caps, developing highly innovative technologies, solutions or platforms

The company must have already raised equity from professional investors, have a sustainable business model and business plan and have a solid corporate governance in place.

Check the "What is eligible" section for the type of projects we can finance.

Investment plans in research & development must be located in the European Union. The projects should be in commercial stage, although pre-commercial stage may be accepted if the company develops technologies in areas of strategic importance to the EU.

The financing size requested is between €5 million and €50 million.

The projects should fall under one of the innovative areas, indicatively:

• Health: biotech, unmet medical needs, vaccines, therapeutics, diagnostics, med-tech, digital health solutions, etc.
• Future technologies: robotics, automation, semi-conductors, high performance computing, quantum computing, artificial intelligence, advanced hardware components, advanced engineering, photonics, semiconductors, IoT, 5g and beyond, edge computing, industry 4.0, automation and data flows, advanced materials, sustainable / advanced manufacturing, space tech, strategic sustainable ICT technologies, etc.
• Sustainable infrastructure: sustainable transport, future mobility, transition to clean energy, decarbonisation technologies and digital solutions, the circular economy, greening of space technologies, etc.

Find information on pricing, geographical availability and other terms